TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.380
+0.050 (1.15%)
Jul 29, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 44.88 | 45.15 | 29.43 | 18.51 | 12.4 | - | |
Revenue Growth | 39.64% | 53.41% | 58.99% | 49.31% | - | - |
Cost of Revenue | 6.7 | 6.97 | 4.1 | 2.61 | 2.26 | - |
Gross Profit | 38.18 | 38.19 | 25.33 | 15.91 | 10.14 | - |
Selling, General & Admin | 51.33 | 50.17 | 43.81 | 40.55 | 25.22 | 3.04 |
Research & Development | 14.89 | 14.97 | 17.69 | 29.84 | 21.36 | - |
Total Operating Expenses | 66.21 | 65.13 | 61.49 | 70.38 | 46.58 | 3.04 |
Operating Income | -28.03 | -26.95 | -36.17 | -54.48 | -36.44 | -3.04 |
Interest Income | 0.65 | 0.56 | 0.4 | 0.43 | 0.18 | 0.06 |
Interest Expense | -5.77 | -5.54 | -3.09 | -0.02 | -0 | - |
Other Non-Operating Income (Expense) | 5.85 | -7.29 | 8.81 | -5.29 | -10.92 | 7.74 |
Total Non-Operating Income (Expense) | 0.72 | -12.27 | 6.13 | -4.88 | -10.74 | 7.81 |
Pretax Income | -27.31 | -39.22 | -30.04 | -59.35 | -47.18 | 4.77 |
Provision for Income Taxes | -0 | 0.01 | 0.01 | 0.01 | 0.01 | - |
Net Income | 10.81 | -39.23 | -30.05 | -59.36 | -47.19 | -4.77 |
Net Income Attributable to Preferred Dividends | -0.71 | 30.46 | 3.19 | 4.24 | 2.83 | - |
Net Income to Common | -58.49 | -69.69 | -33.23 | -63.6 | -50.02 | -4.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 44 | 38 | 25 | 9 | 0 | 0 |
Shares Outstanding (Diluted) | 44 | 38 | 25 | 9 | 0 | 0 |
Shares Change | 64.45% | 49.61% | 169.61% | 2934.71% | 41.31% | - |
EPS (Basic) | -1.41 | -1.84 | -1.31 | -6.77 | -161.55 | -131.65 |
EPS (Diluted) | -1.41 | -1.84 | -1.31 | -6.77 | -161.55 | -131.65 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -20.3 | -18.93 | -41.19 | -51.17 | -32.97 | -1.74 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.46 | -0.50 | -1.63 | -5.45 | -106.48 | -7.93 |
Gross Margin | 85.07% | 84.57% | 86.06% | 85.93% | 81.79% | - |
Operating Margin | -62.45% | -59.68% | -122.88% | -294.28% | -293.91% | - |
Profit Margin | 24.09% | -86.88% | -102.09% | -320.69% | -380.60% | - |
FCF Margin | -45.22% | -41.93% | -139.95% | -276.41% | -265.91% | - |
EBITDA | -27.44 | -26.32 | -35.42 | -53.79 | -36.04 | -3.04 |
EBITDA Margin | -61.13% | -58.29% | -120.35% | -290.59% | -290.70% | - |
EBIT | -28.03 | -26.95 | -36.17 | -54.48 | -36.44 | -3.04 |
EBIT Margin | -62.45% | -59.68% | -122.88% | -294.28% | -293.91% | - |
Effective Tax Rate | 0.01% | -0.02% | -0.02% | -0.02% | -0.02% | 0.00% |